Global Luciferase Assays Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Beta-Galactosidase (Lacz) Assays, Luciferase Assays, Fluorescent Protein Related Assays, Chloramphenicol Acetyltransferase (Cat) Assays, and Others.

By Application;

Gene Expression, Post-Translational Modification, Protein-Protein Interaction, Metabolic Activity, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn752380998 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Luciferase Assays Market (USD Million), 2021 - 2031

In the year 2024, the Global Luciferase Assays Market was valued at USD 1,505.30 million. The size of this market is expected to increase to USD 2,533.69 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.7%.

The global luciferase assays market has experienced substantial growth in recent years, propelled by advancements in biotechnology and the increasing demand for high-throughput screening techniques in drug discovery and development. Luciferase assays, based on the enzyme luciferase, are widely utilized in various research applications, including gene expression analysis, protein-protein interactions, and monitoring cellular processes. The luciferase enzyme catalyzes the oxidation of luciferin, resulting in the emission of light, which can be quantified to measure biological activities. This technology offers several advantages such as high sensitivity, broad dynamic range, and compatibility with automation platforms, making it indispensable in pharmaceutical and biotechnology industries.

One of the key drivers fostering the luciferase assays market growth is the rising prevalence of chronic diseases and the subsequent surge in drug discovery initiatives. With the pressing need for novel therapeutic interventions, pharmaceutical companies are increasingly investing in research and development activities, thereby fueling the demand for luciferase assays. The expanding applications of luciferase assays in academic research, environmental monitoring, and clinical diagnostics are further augmenting market growth. Ongoing technological advancements, such as the development of engineered luciferases with enhanced properties and the integration of luciferase assays with other analytical techniques, are poised to widen the scope of applications, thus driving market expansion. The high cost associated with luciferase assay kits and the complexity of data analysis pose challenges to market growth, necessitating efforts to address these concerns through cost-effective solutions and user-friendly software platforms.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By Region
  4. Global Luciferase Assays Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increased demand for drug discovery screening
        2. Biotech and molecular biology advancements
        3. Growing need for efficient disease diagnostics
        4. Lucrative applications in gene expression analysis and diagnostics
      2. Restraints
        1. Standardization challenges
        2. Sample stability and performance concerns
        3. Limited compatibility in certain conditions
      3. Opportunities
        1. Integration with automation for screening
        2. Expansion into clinical diagnostics
        3. Partnerships with pharma for drug development
        4. Studying cellular pathways and drug effects
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Luciferase Assays Market, By Type, 2021 - 2031 (USD Million)
      1. Beta-Galactosidase (Lacz) Assays
      2. Luciferase Assays
      3. Fluorescent Protein Related Assays
      4. Chloramphenicol Acetyltransferase (Cat) Assays
      5. Others
    2. Global Luciferase Assays Market, By Application, 2021 - 2031 (USD Million)
      1. Gene Expression
      2. Post-Translational Modification
      3. Protein-Protein Interaction
      4. Metabolic Activity
      5. Others
    3. Global Luciferase Assays Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape Analysis
    1. Company Profiles
      1. Life Technologies
      2. Sigma Aldrich
      3. Thermo Fisher
      4. Promega
      5. nvivogen
      6. Roche Applied Sciences
      7. Switchgear Genomics
      8. Perkin Elmer
      9. EMD Millipore
  7. Analyst Views
  8. Future Outlook of the Market